Pregnancy after radioiodine therapy
Heinze, H.G.
Deutsche Medizinische Wochenschrift 112(41): 1593
1987
ISSN/ISBN: 0012-0472 PMID: 3665741 Document Number: 291356
Document emailed within 1 workday
Related Documents
Schiavo, M.; Bagnara, M.C.; Pomposelli, E.; Altrinetti, V.; Calamia, I.; Camerieri, L.; Giusti, M.; Pesce, G.; Reitano, C.; Bagnasco, M.; Caputo, M. 2013: Radioiodine therapy of hyperfunctioning thyroid nodules: usefulness of an implemented dose calculation algorithm allowing reduction of radioiodine amount Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 57(3): 301-307Evans, P.M.; Webster, J.; Evans, W.D.; Bevan, J.S.; Scanlon, M.F. 1998: Radioiodine treatment in unsuspected pregnancy Clinical Endocrinology 48(3): 281-283
Urbannek, V.; Voth, E.; Moka, D.; Schicha, H. 2001: Radioiodine therapy of Graves' disease--a dosimetric comparison of various therapy regimens of antithyroid agents NUKLEARMEDIZIN. Nuclear Medicine 40(4): 111-115
Bakheet, S.M.; Hammami, M.M.; Powe, J. 1996: False-positive radioiodine uptake in the abdomen and the pelvis: radioiodine retention in the kidneys and review of the literature Clinical Nuclear Medicine 21(12): 932-937
Misaki, T. 2006: Hypothyroidism after radioiodine therapy Nihon Rinsho. Japanese Journal of Clinical Medicine Suppl 1: 392-394
O'Connell, J.; Hayes, F. 2012: Radioiodine therapy for hyperthyroidism Irish Medical Journal 105(3): 69-70
Feldt-Rasmussen, U.F. 2001: Radioiodine therapy of cancer metastases? Ugeskrift for Laeger 163(24): 3367
Salvatori, M.; Rufini, V.; Garganese, M.C.; Di Giuda, D. 2000: Radioiodine therapy in differentiated thyroid carcinoma Rays 25(2): 221-238
Horácek, Jí. 2015: Radioiodine therapy in patients with low-thyroid cancer Vnitrni Lekarstvi 61(9): 755-757
Sonne, H.S.; Larsen, B.; Asfeldt, V.H. 1993: Radioiodine therapy of thyrotoxicosis in a central hospital Ugeskrift for Laeger 155(43): 3483-3486
Dietlein, M.; Dressler, J.; Farahati, J.; Leisner, B.; Moser, E.; Reiners, C.; Schicha, H.; Schober, O. 1999: Guidelines for radioiodine therapy (RIT) in differentiated thyroid cancer Nuklearmedizin. Nuclear Medicine 38(6a): 221-222
Moser, E. 1997: Radioiodine therapy of Basedow's disease--is there a therapeutic standard? Zentralblatt für Chirurgie 122(4): 227-230
Czarnywojtek, A.; Czepczynski, R.; Ruchala, M.; Wasko, R.; Zgorzalewicz-Stachowiak, M.; Szczepanek, E.; Zamyslowska, H.; Bartkowiak, Z.; Florek, E.; Sowinski, J. 2009: Radioiodine therapy in patients with amiodarone-induced thyrotoxicosis (AIT) Neuro Endocrinology Letters 30(2): 209-214
Schicha, H.; Dietlein, M. 2002: Graves' disease nd toxic nodular goiter--radioiodine therapy NUKLEARMEDIZIN. Nuclear Medicine 41(2): 63-70
Seeger, T.; Emrich, D.; Sandrock, D. 1995: Radioiodine therapy of funcitonal autonomy using the functional autonomous volume NUKLEARMEDIZIN. Nuclear Medicine 34(4): 135-140
Claimon, A.; Pusuwan, P.; Khiewvan, B. 2017: Factors Influencing the Success of the first Radioiodine Therapy for Differentiated Thyroid Carcinoma Journal of the Medical Association of Thailand 100(2): 207-218
Dietlein, M.; Troche, C.J.; Moka, D.; Bausch, V.; Lauterbach, K.W.; Schicha, H. 1998: Consequences of new patient discharge guidelines on the cost structure of radioiodine therapy Nuklearmedizin. Nuclear Medicine 37(1): 33-40
Walter, M.A.; Müller, B.; Müller-Brand, J. 2003: Does an individual estimation of halflife improve the results of radioiodine therapy of Graves' disease? NUKLEARMEDIZIN. Nuclear Medicine 42(3): N29; Author Reply N29
Dunkelmann, S.; Rudolph, F.; Prillwitz, A.; Groth, P.; Schümichen, C. 1998: Paradoxical effect of radioiodine therapy in functional thyroid autonomy and mild immunothyropathy NUKLEARMEDIZIN. Nuclear Medicine 37(1): 23-29
Krohn, T.; Meyer, P.T.; Ocklenburg, C.; Knollmann, D.; Nowak, B.; Schaefer, W.M. 2008: Stunning in radioiodine therapy of benign thyroid disease. Quantification and therapeutic relevance NUKLEARMEDIZIN. Nuclear Medicine 47(6): 248-254